SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM OF CANDESARTAN CILEXETIL WITH IMPROVED BIOAVAILABILITY
Abstract
Candesartan is an angiotensin II receptor blocker with inherent low bioavailability. The present studies entail the optimization and evaluation of self- nanoemulsifying drug delivery system (SNEDDS) of Candesartan in order to enhance its oral bioavailability. For this Capryol 90, Captex 500, Labrasol were used as oil, surfactant and co surfactant respectively. FTIR studies revealed no interaction among the drug and polymers used in the formulation. Based on the physicochemical parameters and in-vitro dissolution studies, F17 prepared with Smix (Surfactant: Co-surfactant) of 3:1 and Oil:Smix of 6:4, was found to be an optimum one. The formulation F17 was found to release 99.12 ± 5.10% drug at the end of one hour and scanning electron microscopic analysis showed nanosized particles. The droplet size of the optimized formulation was found to be 51.7 nm & Z-Average of 59.2 nm. The zeta potential of the optimized formulation (F17) was found to be -15.5 mV. The formulations were also found to be stable over a period of 6 months of testing. From in vivo bioavailability studies Cmax of the SNEDDS 35.2 ± 0.02 ng/ml was significant (p<0.05) as compared to the pure drug suspension formulation 25.1 ± 0.03ng/ml. Tmax of both SNEDDS formulation and pure drug suspension was 1.00 ± 0.03 h and 2.00 ± 0.01 h, respectively. AUC is an important parameter in evaluating bioavailability of drug from dosage form, AUC0-∞ infinity for SNEDDS formulation was higher (160.1±1.04ng. h/ml) than the pure drug suspension formulation 135.3 ± 2.02 ng.h/ml. Statistically, AUC0-t of the SNEDDS formulation was significantly higher (p<0.05) as compared to pure drug suspension formulation. Higher amount of drug concentration in blood indicated better systemic absorption of Candesartan from SNEDDS formulation as compared to the pure drug suspension formulation. The results from this study suggest the requirement for potential use of candesartan as self-nanoemulsifying drug delivery systems.
Keywords:
Candesartan, Hypertension, SNEDDS, Caproyl 90, Captex, 500, Zeta PotentialDOI
https://doi.org/10.25004/IJPSDR.2018.100501References
2. Nekkanti V, Kalepu S. Development of novel lipid based drug delivery system for Raloxifine Hydrochloride. International Research Journal of Pharmacy. 2012; 3(9): 166-173.
3. Hao DC, Ge GB, Xiao PG, Wang P, Yang L. Drug metabolism and Pharmacokinetic diversity of Ranunculaceae medicinal compounds. Current Drug Metabolism. 2015; 16: 294-321.
4. Amidon G, Lennarnas H, Shah V, Crison J. A theoretical basis for a biopharmaceutics drug classification. The correlation of in-vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995; 12: 413–29.
5. Aulton M. The design and manufacture of medicin. Edn 3, Elsevier publisher of health science books and journals. 2007, pp. 320.
6. Thomas L. Lekme, David A.Williams, Victoria F, Roche S, William Zito. Foye’s principles of medicinal chemistry. 2008, pp. 75.
7. Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001; 50(1):61–80.
8. Xu H, He L, Nie S, Guan J, Zhang X, Yang X. Optimized preparation of Vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits. J Control Release. 2009; 140(1): 61–8.
9. Patel J, Kevin G, Patel A, Raval M, Sheth N. Design and development of a self-nanoemulsifying drug delivery system for Telmisartan for oral drug delivery. International Journal of Pharmaceutical Investigation. 2011; 1(2): 112-118.
10. Sermkaew N, Ketjinda W, Boonme P, Phadoongsombut N, Wiwattanapatapee R. Liquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from crude extract of Andrographis paniculata. European Journal of Pharmaceutical Sciences. 2013; 50(3–4):459–66.
11. Kaur G, Chandel P, Harikumar SL. Formulation Development of Self Nanoemulsifying Drug Delivery System (SNEDDS) of Celecoxib For Improvement of Oral Bioavailability. Pharmacophore. 2013; 4(4):120-133.
12. Gupta AK, Mishra DK, Mahajan SC. Preparation and in-vitro evaluation of self-emulsifying drug delivery system of antihypertensive drug, Valsartan. 2011; 2 (3): 633-639.
13. Bhikshapathi DVRN, Madhukar P, Dilip KB, Aravind KG. Formulation and characterization of Pioglitazone HCl self-emulsifying drug delivery system. Scholars Research Library. 2013; 5 (2): 292-305.
14. Raval C, Joshi N, Patel J, Upadhyay UM, Enhanced Oral Bioavailability of Olmesartan by using Novel Solid Self Emulsifying Drug Delivery System, International Journal of Advanced Pharmaceutics 2012; 2(2): 82-92.
15. Vanita SS, Subhashini NJP. Novel Self-Nanoemulsion Drug Delivery System of Fenofibrate with Improved Bio-Availability. Int J Pharm Bio Sci. 2013. 4(2): 511-521.
16. Vijaykumar N, Zhijun W, Guru VB. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes versus Self-nanoemulsifying drug delivery systems. AAPS Pharm Sci Tech. 2016; 17 (4): 851-862.
17. Ruan G, Feng SS. Preparation and Characterization of Poly (lactic acid) - poly (ethylene Glycol)-poly lactic acid (PLA-PEG-PLA) microspheres for the controlled release of Paclitaxel. Biomaterials. 2003; 24: 5307-44.
18. Zhongcheng K, Xuefeng H, Xiao-bin J. Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Design Development and Therapy. 2016. 10: 2049-2060.
19. Lalit KT, Mohan LK. Stability Study and In-vivo Evaluation of Lornoxicam Loaded Ethyl Cellulose Microspheres. International Journal of Pharmaceutical Sciences and Drug Research, 2014; 6(1): 26-30.
20. Misra A, Shahiwala A. In-Vitro and In-Vivo Tools in Emerging Drug Delivery Scenario: Challenges and Updates. In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes. 2018; 22: 19-42.
21. Bhatt P, Lalani R, Vhora I, Patil S, Amrutiya J, Misra A, Mashru R. Liposomes encapsulating native and cyclodextrin enclosed Paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. International Journal of Pharmaceutics. 2018; 536: 95-107.
22. Jinjie Zhang, Qiang Peng, sanjun shi Qiang Zhang, Xun sun, Tao gong1 Zhirong Zhang, Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. International Journal of Nanomedicine. 2011; 6: 3405- 16.
23. Veeranjaneyulu D, Aneesha A, Nandakishore Agarwal Stability Indicating RP-HPLC Method For The Simultaneous Determination of Candesartan Cilexetil And Hydrochlorothiazide In Bulk And Dosage Forms. Indian Journal of Research in Pharmacy and Biotechnology. 2011; 1(5): 720-724.
Published

